Key facts
- It has raised $16.7M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Creative Destruction Lab, Google for Startups, ventureLAB Innovation Centre, Scale Good Fund, Scale Up Canada — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for PulseMedica
- ·The full record, as it builds
Funding rounds
No funding rounds for PulseMedica are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PulseMedica
Developer of an imaging and medical platform designed to provide non-invasive vitreoretinal treatments for various eye diseases. The company's platform leverages advanced imaging technology, embedded machine learning, and laser technology to diagnose, plan, and treat diseased areas within the eye, such as age-related macular degeneration, diabetic retinopathy, branch retinal vein occlusion, and glaucoma, enabling patients to receive treatment options to cure retinal diseases.
- Sector
- Healthcare
- HQ
- Edmonton, Canada
- Founded
- 2018
- Employees
- 39
- Website
- pulsemedica.com/
- Ownership
- Privately Held (backing)
PulseMedica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PulseMedica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PulseMedica in its N-PORT filings yet. We sweep new filings monthly.